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Abstract. Prostate cancer is the second most commonly occurring cancer in men. 
Diagnosis through Magnetic Resonance Imaging (MRI) is limited, yet current 
practice holds a relatively low specificity. This paper extends a previous SPIE 
ProstateX challenge study in three ways 1) to include healthy tissue analysis, cre-
ating a solution suitable for clinical practice, which has been requested and vali-
dated by collaborating clinicians; 2) by using a voting ensemble method to assist 
prostate cancer diagnosis through a supervised SVM approach; and 3) using the 
unsupervised GTM to provide interpretability to understand the supervised SVM 
classification results. Pairwise classifiers of clinically significant lesion, non-sig-
nificant lesion, and healthy tissue, were developed. Results showed that when 
combining multiparametric MRI and patient level metadata, classification of sig-
nificant lesions against healthy tissue attained an AUC of 0.869 (10-fold cross-
validation). 
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1 Introduction 
Prostate cancer is the second most commonly occurring cancer in men worldwide [1]. 
Diagnosis through Magnetic Resonance Imaging (MRI) is the second line of diagnosis, 
usually after a trans-rectal ultrasound biopsy which is conducted after a positive blood 
screening test. However, this test has a relatively low specificity, leading to overdiag-
nosis and therefore overtreatment.  
Although MRI diagnosis can overcome this, it requires specialist knowledge to re-
view the prostate MRI, which is time consuming. Furthermore, the abundance of avail-
able MRI data can provide difficulty with where to begin. This study uses both Gener-
ative Topographic Mapping (GTM) and Support Vector Machines (SVMs) as assisting 
tools, in visualization and classification respectively, for the diagnosis of prostate can-
cer on multiparametric MRI (mpMRI) scans, through a voting ensemble technique. 
Upon request from collaborating clinicians, the SPIE ProstateX challenge dataset [2]  
was extended in this study from its original use, whereby the contralateral of the lesion 
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location may be taken as healthy prostate tissue. This extends from the two classes 
available in the data set – the clinically significant lesions and non-significant lesions. 
The latter are denoted “non-significant” as prostate cancer treatment is not always 
needed for a lesion of a lower Gleason score [3]. 
The use of the contralateral to attain healthy tissue denotes a novel point for this 
study. Through pairwise tests of the three classes, the voting ensemble technique gives 
rise to a diagnosis aiding tool which is in demand from clinicians and radiologists. 
Recent research from the ProstateX challenge tackles the two class problem – clini-
cally significant against non-significant – with various machine learning methods such 
as deep learning [4], convolutional neural networks [5] and SVMs [6]; the efficiency 
of the latter inspiring its use in this study. The use of the GTM in this work provides 
insight into the structure of the data set, to allow for an explanation of the results of the 
ensemble voting method. 
The Data & Classification Methods section details how the ProstateX challenge data 
set has been pre-processed and the setup of the SVM. The Model Evaluation section 
shows the ensemble voting systems results, with an Application to prostate lesion find-
ings following. Using the GTM, an unsupervised explanation into the hidden data struc-
ture is presented, providing interpretability to the supervised SVM classifier. 
2 Data  
The ProstateX challenge training data used for this study is a collection of 330 lesion 
findings over 204 patients, each with mpMRI taken around the prostate. Metadata for 
each lesion finding, and the findings within each scan parameter were held in separate 
files. For each patient, one or more prostate lesions with their location were identified 
through its scanner coordinate position. Each lesion within the metadata holds a level 
denoting its clinical significance; where it is clinically significant if the Gleason score 
of the lesion is 7 or higher, or non-significant where the Gleason score is 6 or below. 
The numeric Gleason score of a given lesion is not available in the data set. 
This work extends on the original ProstateX challenge data based on a request from 
collaborating clinicians. Through using the contralateral of the lesion location, healthy 
tissue can be extracted. The total number of significant cases in the dataset is 76, while 
the non-significant cases amount to 254. As these are imbalanced classes, we decided 
to subsample the class of non-significant cases to only 75 cases. In line with this, a total 
of 54 healthy tissue samples were extracted. Three of the various mpMRI scan param-
eters are analyzed in this study: T2-weighted, Ktrans and Apparent Diffusion Coefficient 
(ADC). Only transverse images were used. These modalities are all shown to be related 
to lesion clinical significance [7]. 
T2-weighted imaging is a form of spin-echo pulse sequencing, showing fatty tissue 
and fluid brightly. ADC is a measure of the magnitude of diffusion (of water molecules) 
within tissue and is calculated from diffusion weighted imaging. Ktrans, a type of perfu-
sion imaging,  represents a measure of capillary permeability, calculated from dynamic 
contrast-enhanced imaging. 
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3 Classification methods 
For creating the classifiers we follow the steps outlined below: 
a) Pre-processing: The ProstateX dataset is a large data set, with each patient 
holding multiple scan parameters each – furthermore, the naming of the files 
was not consistent. Various rules were required to extract the relevant data. 
Metadata was collected from both the separate files, and the DICOM header 
data of the relevant image files; including the patient age which is used within 
the fitted models. 
b) Patch Extraction and vectorization of the data: For each lesion, a centered 5mm 
x 5mm patch is extracted at a resolution of 1px/mm for each of the three MRI 
scan parameters. The contralateral is defined as the opposite side of the MRI 
image to which the lesion is located. For example, if the lesion is located 25mm 
to the left of the center of the MRI image, then the contralateral is located 25mm 
to the right of the center of the MRI image, as validated by collaborating clini-
cians. They were used as the ‘healthy’ tissue data and is suitable for analysis as 
informed by collaborating clinicians. For the selection of those healthy samples, 
we identified the patient with only one lesion finding (as indicated in the 
metadata), which is of a certain distance away from the center of the image. In 
these cases, also a 5mm x 5mm patch was extracted at a resolution of 1px/mm 
for each of the three MRI scan parameters (as in the lesion patch extraction), 
following the method of a successful submission to the SPIE ProstateX chal-
lenge [6]. Images were flattened into 75 dimensional vectors. All processing 
was carried out with 32-bit floating point pixel values, preserving large dy-
namic range and subtle contrast differences. These vectors can be further aug-
mented with patient level metadata, as described. 
c) Augmenting the vectors with patient level metadata: For the model presented in 
this study, the image data vector is further augmented with patient level 
metadata. The first is the zonal location of the region of interest (lesion or 
healthy tissue) within the prostate, denoted as a dummy variable. The second is 
the patient age. 
d) Data standardization: Each input dimension is scaled – for Ktrans images, this 
is through the log transform. For all other input dimensions, this is through sub-
traction of the mean and division of the standard deviation. This ensures that 
the distribution of each dimension is approximately normal, again similar to 
[6]. 
e) Classification using Support Vector Machines: For this classification study 
upon three class labels through pairwise testing, Support Vector Machines were 
utilized, as first described in [8]. SVM was successfully applied to this data in 
[6]. The linear kernel is not suitable for this data set – it was tested but discarded 
due to poor performance. The kernel selected for this work is the radial basis 
function (RBF-SVM), as defined in Equation 1. Through defining the kernel 
function there is no need to perform ∅(. ) explicitly. 
 𝐾(𝑥𝑖 , 𝑥𝑗) = ∅(𝑥𝑖)𝑇∅(𝑥𝑗) = exp (−𝛾‖𝑥𝑖 − 𝑥𝑗‖
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) , 𝛾 > 0 (1) 
f) Initial cross-validation on all data for hyperparameter selection: Two hyperpa-
rameters require tuning for an RBF-SVM: the soft-margin constant, C and the 
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kernel parameter, 𝛾. A cross validation is used to evaluate each data combina-
tion and pairwise test, to find the best set of parameters. A grid search was 
carried out on C ∈ {0.1, 0.5, 1, 2, 5, 10, 20, 30, 50} and 𝛾 ∈ {1.0, 0.2, 0.1, 0.05, 
0.01, 0.001, 0.0001, 0.00001}. For the results presented in this paper, the 10-
fold cross validation results across all the data are presented in Table 1. 
4 Model Evaluation: Using a Voting Ensemble method for 
aiding prostate cancer diagnosis 
In this study, a voting ensemble method across the three pairwise classifiers are pro-
posed to give a final classification of each finding. This is to evaluate the system as a 
classifier. The majority vote across all classifiers is taken to be the final classification 
label. An undecided category was added for the cases where all three classifiers predict 
something different and a majority vote cannot be reached. In this case, as a tool for 
aiding diagnosis, a clinician would be alerted to this case for an expert to classify it 
themselves.  
The voting ensemble method is evaluated through a 10-fold cross validation. Within 
each fold, 90% of the data is used for training and 10% of the data is partitioned ac-
cording to the frequencies of the data, for testing the voting ensemble methodology. 
The results of each fold are used to calculate the classification across the data set used 
for this study. Each of the pairwise classifier is trained using the RBF-SVM with the 
parameters found through the cross-validation grid search (as explained in section 2.6). 
The results of applying the voting ensemble method (after cross validation) to the pair-
wise classifiers created using all image patch data and patient metadata is presented in 
Table 2. 
For the significant cases, 72.4% of them were correctly classified as significant, with 
the majority of the misclassifications (23.6%) going to the non-significant lesions class. 
Only three cases (3.9%) were incorrectly classified as healthy tissue, and no cases were 
classified as undecided. In turn, the healthy tissue was correctly classified a 68.5% of 
the time, while again the majority of misclassification (25.9%) went to the non-signif-
icant class, and only 2 cases fell into the significant class. 
The non-significant cases were correctly classified only 48.0% of the time, however, 
considering that this class is the intermediate between having a healthy prostate and a 
significant tissue, this is to some extent expected. Still, this is the less critical issue from 
the clinical viewpoint, as it is known that treatment is not always needed for non-sig-
nificant prostate cancers [3] and techniques such as active surveillance may be em-
ployed within the patients care plan. Potentially, those non-significant cases predicted 
as significant (20%) will undergo more in-depth analysis, which may result in their 
final correct diagnosis as non-significant; and those predicted as healthy (32%) may 
hold a very low Gleason score and therefore closely resemble healthy prostate tissue. 
The latter group must probably would not require any treatment, therefore the risk to 
the patients is not considered high. 
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5 Classification results: Application to prostate lesion findings 
An application of the ensemble voting system applied to given lesion findings and 
healthy tissue is presented in Figure 1. For cases A and B, a significant and non-signif-
icant lesion finding respectively, are classified through the three classifiers. For case C, 
the ensemble voting system is shown to classify healthy prostate tissue. In all three of 
these cases, the majority vote matches the original label and is therefore correctly clas-
sified. It is intended that this aids prostate lesion diagnosis. 
However, for case D, which is known to be healthy prostate tissue, there is no ma-
jority vote; all three pairwise classifiers have predicted differently. In practice, this 
would be brought to the attention of a clinician, for their technical knowledge to make 
the final decision. Nevertheless, in all cases, lesion or not, the final decision would rest 
with them as this tool is designed to aid diagnosis. 
 
Table 1: 10-fold cross validation results for hyperparameter grid search. 
Classifier AUC Standard deviation C 𝛾 
Significant vs. Non-significant 0.722 0.262 50 0.001 
Significant vs. Healthy 0.869 0.099 0.5 0.01 
Non-significant vs. Healthy 0.713 0.134 2 0.01 
 
Table 2: Results of the voting ensemble method applied to the dataset containing all image 
patch data and patient metadata. 
6 Discussion: Explanation of the classification results using 
Generative Topographic Mapping 
Through visualizing the data in the latent space, it is possible to explain the supervised 
SVM classification results using the unsupervised GTM [8]. GTM is a nonlinear latent 
variable model of the manifold learning family, with sound foundations in probability 
theory. It performs simultaneous clustering and visualization of the observed data 
through a nonlinear and topology-preserving mapping from a visualization latent space 
in (with being usually 1 or 2 for visualization purposes) onto a manifold embedded in 
a multi-dimensional space, where the observed data reside. The mapping that generates 
the manifold is carried out through a generalized additive regression function: 
 
𝑦 =  𝑊𝜑 (𝑢) (2) 
 
 
Original label 
No. 
cases 
Final predicted label 
Significant Non-significant Healthy Undecided 
Significant 76 55 18 3 0 
Non-significant 75 15 36 24 0 
Healthy 54 2 14 37 1 
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where y ∈ D, u ∈, W is the matrix that generates the mapping, and φ is a vector with 
the images of S basis functions φs. To achieve computational tractability, the prior dis-
tribution of u in latent space is constrained to form a uniform discrete grid of M centers, 
analogous to the layout of the Self-Organizing Map (SOM, [9]) units, in the form of a 
sum of delta functions: 
𝑝(𝒖) =
1
𝐾
∑ 𝛿(𝒖 − 𝒖𝑘)
𝐾
𝑘=1
(3) 
Similar to how the RBF kernel has been used in this application through the SVM 
classifier, GTM typically uses a set of radial basis functions to map the results of the 
unsupervised analysis. By doing this, the interpretability problem of the SVM is some-
what alleviated. The similar kernel tricks allow for interpretation.  
Figure 2 and Figure 3 show the mean projections for Significant against Healthy, 
and for all three classes respectively. Clustering can be seen within Figure 2 for both 
the Significant and the Healthy classes within the latent space. However, with the in-
troduction of the Non-significant class, there is no clustering and it ‘invades’ both the 
Significant and the Healthy classes. To an extent this is to be expected. Where the 
Gleason score of a Significant lesion is 7 or higher, some Non-significant lesions at the 
higher end of their possible Gleason scores, such as 5 or 6, may overlap with the Sig-
nificant class. Similarly, those with a lower Gleason score, such as 1 or 2, may overlap 
with the Healthy class.  
 
Figure 1: Application of the voting ensemble method to lesion findings. A: Classification of a 
Clinically Significant Lesion. B: Classification of a non-significant lesion. C: Classification of 
healthy tissue. D: Disagreement throughout the ensemble voting system. (yo – years old) 
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Figure 4 shows the boxplot of the distributions of the mean projections of the points. 
All classes overlap, which is to be expected as shown in Figure 3. The interquartile 
ranges of the Significant class and the Healthy class, showing separation (as shown in 
Figure 2). The interquartile range of the Nonsignificant class overlaps with both the 
Significant class and the Healthy class.  
 
 
Figure 2: Mean projections in the latent space using GTM: Significant against Healthy. Clus-
tering is present. 
 
Figure 3: Mean projections in the latent space using GTM: all three classes. The clustering 
becomes distorted with the introduction of the non-significant (blue) class. 
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Figure 4: Boxplots of the distributions of the mean projections for each class label. 
Through the addition of the healthy class, the initial 2-class classifier problem of the 
ProstateX challenge can be visualized, with much overlap of the Non-significant class 
within the Significant class. Submissions to the ProstateX challenge were for the 2-
class classifier problem using AUC and hence comparisons are not presented alongside 
this study; enhanced interpretability using the GTM with the binary classifiers is pro-
vided. 
6.1 Borderline cases 
 
Figure 5: Examples of borderline cases - both are Non-significant lesions but appear within 
other clusters in the latent space, with the multiparametric profile displayed for each case. 
Figure 5 shows examples of borderline cases of cases of Non-Significant lesions from 
the latent space, where case A is an example of a Non-significant lesion which is located 
within the Significant clustering, and case B is an example of a Non-significant lesion 
which is located within the Healthy clustering. 
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Reasons why cases A and B appear on different corners of the latent space visuali-
zation, in terms of the multiparametric images, may be because of the differences in 
brightness of the images. Although both Non-significant cases, case A for example may 
appear similar to the brightness of a Significant case and is therefore closer to that clus-
tering. Indeed, the Gleason score is not available with the challenge data set and this 
would provide interesting insights. 
7 Conclusions and further work 
This study found that using an ensemble voting method across three classifiers, a ma-
jority vote system can assist clinicians in the diagnosis stage of a patient’s cancer care. 
The use of healthy tissue has been included through demand and validation from clini-
cians. Through using a supervised SVM, the results can be explained, with enhanced 
interpretation, through an unsupervised visualization method, the GTM.  
Further work will look at increasing the classifiers scope, leading to segmentation 
maps of the area to further aid diagnosis, particularly for non-invasive treatment tech-
niques. Furthermore, utilizing the decision of a clinician with their classification of an 
undecided case through active machine learning techniques will be studied. 
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